Chun Zhang

Chun Zhang

Auto-generated profile, based on publicly available information

Chun Zhang

Department of Otolaryngology School of Medicine, South China University of Technology Guangzhou China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2022 in The Laryngoscope
Verified
Journal Article
Closed access
CZChun Zhang
Chun Zhang
ZLZhi Liu
Zhi Liu
JZJinhong Zhang
Jinhong Zhang
XWXiaoyu Wang
Xiaoyu Wang
JWJiasen Wang
Jiasen Wang
LLLianLian Liu
LianLian Liu

2 November 2022 in Laryngoscope Investigative Otolaryngology
Verified
Journal Article
Open access
YPYufei Pan
Yufei Pan
JLJinrang Li
Jinrang Li
XWXiaoyu Wang
Xiaoyu Wang
JZJinhong Zhang
Jinhong Zhang
CZChun Zhang
Chun Zhang
ZLZhi Liu
Zhi Liu
Objective: This study aimed to develop an objective and simple score for predicting the prognosis of patients with laryngeal contact granuloma (LCG) treated with local glucocorticoid injection combined with oral proton pump inhibitor (GI + PPI).Methods: Cox regression analysis was used to analyze the effect of baseline variables on the prognosis of 507 patients with LCG treated with GI + PPI. An easy‐to‐apply RCGSG (Reflus, Cough, Gender, and Surgery in GI + PPI therapy) score was developed based on the independent risk factors selected by univariate and multivariate Cox regression analyses. The score was internally validated by receiver‐operating characteristic curve, calibration curve, and decision curve analysis.Results: After univariate and multivariate analyses, male gender (hazard ratio [HR] 0.546, p < .001), laryngopharyngeal reflux (HR 0.702, p = .001), chronic cough (HR 0.709, p = .001), and history of surgical resection (HR 0.433, p < .001) were found to be the independent risk factors affecting the prognosis of LCG. According to the score, the median cure time was 3 months (95% confidence interval [CI] 2.81–3.19) in the low‐risk group, 4 months (95% CI 3.74–4.26) in the moderate‐risk group, and 5 months (95% CI 4.76–5.24) in the high‐risk group. The bootstrap method was used to plot calibration curves for internal validation.Conclusion: The RCGSG score, developed based on laryngopharyngeal reflux, chronic cough, gender, and surgical resection history, has been internally verified to be a good predictor of the prognosis of patients with LCG receiving GI + PPI treatment.Level of evidence: Level 4.